The Director-General of NAFDAC, Prof. Mojisola Adeyeye, while delivering a presentation at the Invest Nigeria Conference & Expo 4.0, hosted by the Lagos Chamber of Commerce and Industry at Eko Hotels and Suites, Victoria Island, Lagos. Photo: NAFDAC
The Director-General of the National Agency for Food and Drug Administration and Control, Prof. Mojisola Adeyeye, has highlighted the agency’s regulatory reforms and their impact on local manufacturing and investment in Nigeria’s health products sector.
According to a statement shared on the agency’s official X account on Wednesday, Adeyeye spoke at the Invest Nigeria Conference & Expo 4.0, hosted by the Lagos Chamber of Commerce and Industry at Eko Hotels and Suites, Victoria Island, Lagos.
In a presentation titled “The Roles of NAFDAC with Regards to Investments in Nigeria,” the NAFDAC DG outlined regulatory measures introduced by the agency and the gains recorded in local production and investment.
Adeyeye highlighted NAFDAC’s sustained Maturity Level 3 status, describing it as the highest benchmarking rating in Africa, as well as Nigeria’s full membership of the International Council for Harmonisation, attained in November 2025.
